This study confirms significant diagnostic challenges in distinguishing non-invasive implants of borderline serous tumors from low-grade serous carcinoma metastases among pathologists, highlighting the need for developing and implementing standardized diagnostic algorithms.
Badlaeva et al. (Tue,) studied this question.